Calcific aortic stenosis

[1]  S. Takagi,et al.  Natural History , 2019, Nature.

[2]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[3]  Sara General.  Skeleton key , 2016, Nature.

[4]  M. Mack,et al.  A Randomized Evaluation of the SAPIEN XT Transcatheter Heart Valve System in Patients With Aortic Stenosis Who Are Not Candidates for Surgery. , 2015, JACC. Cardiovascular interventions.

[5]  P. Pibarot,et al.  Outcome and Impact of Aortic Valve Replacement in Patients With Preserved LVEF and Low-Gradient Aortic Stenosis. , 2015, Journal of the American College of Cardiology.

[6]  Y. Bossé,et al.  Calcium Signaling Pathway Genes RUNX2 and CACNA1C Are Associated With Calcific Aortic Valve Disease , 2015, Circulation. Cardiovascular genetics.

[7]  Y. Bossé,et al.  Oxidized Phospholipids, Lipoprotein(a), and Progression of Calci fi c Aortic Valve Stenosis , 2017 .

[8]  E. V. van Beek,et al.  Valvular (18)F-Fluoride and (18)F-Fluorodeoxyglucose Uptake Predict Disease Progression and Clinical Outcome in Patients With Aortic Stenosis. , 2015, Journal of the American College of Cardiology.

[9]  Y. Bossé,et al.  Autotaxin Derived From Lipoprotein(a) and Valve Interstitial Cells Promotes Inflammation and Mineralization of the Aortic Valve , 2015, Circulation.

[10]  E. Aikawa,et al.  A Not-So-Little Role for Lipoprotein(a) in the Development of Calcific Aortic Valve Disease. , 2015, Circulation.

[11]  M. Dweck,et al.  Calcification in Aortic Stenosis: The Skeleton Key. , 2015, Journal of the American College of Cardiology.

[12]  Hongyan Qiao,et al.  2-Year Outcomes in Patients Undergoing Surgical or Self-Expanding Transcatheter Aortic Valve Replacement. , 2015, Journal of the American College of Cardiology.

[13]  Y. Bossé,et al.  The pathology and pathobiology of bicuspid aortic valve: State of the art and novel research perspectives† , 2015, The journal of pathology. Clinical research.

[14]  M. Mack,et al.  5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial , 2015, The Lancet.

[15]  M. Mack,et al.  5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial , 2015, The Lancet.

[16]  M. Mack,et al.  Propensity-Matched Comparisons of Clinical Outcomes After Transapical or Transfemoral Transcatheter Aortic Valve Replacement: A Placement of Aortic Transcatheter Valves (PARTNER)-I Trial Substudy , 2015, Circulation.

[17]  Magdi H Yacoub,et al.  Expression of smooth muscle cell markers and co-activators in calcified aortic valves. , 2015, European heart journal.

[18]  R. Lange,et al.  Perioperative Results and Complications in 15,964 Transcatheter Aortic Valve Replacements: Prospective Data From the GARY Registry. , 2015, Journal of the American College of Cardiology.

[19]  L. W. Andersen,et al.  Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Valve Stenosis: 1-Year Results From the All-Comers NOTION Randomized Clinical Trial. , 2015, Journal of the American College of Cardiology.

[20]  Marie-Chloé Boulanger,et al.  Innate and Adaptive Immunity in Calcific Aortic Valve Disease , 2015, Journal of immunology research.

[21]  Y. Bossé,et al.  Carbonic anhydrase XII in valve interstitial cells promotes the regression of calcific aortic valve stenosis. , 2015, Journal of molecular and cellular cardiology.

[22]  P. Pellikka,et al.  Effect of Left Ventricular Ejection Fraction on Postoperative Outcome in Patients With Severe Aortic Stenosis Undergoing Aortic Valve Replacement , 2015, Circulation. Cardiovascular imaging.

[23]  R. Hinton,et al.  COX2 Inhibition Reduces Aortic Valve Calcification In Vivo , 2015, Arteriosclerosis, thrombosis, and vascular biology.

[24]  M. Mack,et al.  Propensity-Matched Comparisons of Clinical Outcomes after Transapical or Transfemoral TAVR: A PARTNER-I Trial Substudy , 2015 .

[25]  M. Mack,et al.  Effect of Tricuspid Regurgitation and the Right Heart on Survival After Transcatheter Aortic Valve Replacement: Insights From the Placement of Aortic Transcatheter Valves II Inoperable Cohort , 2015, Circulation. Cardiovascular interventions.

[26]  Marie-Chloé Boulanger,et al.  Adenosine derived from ecto-nucleotidases in calcific aortic valve disease promotes mineralization through A2a adenosine receptor. , 2015, Cardiovascular research.

[27]  B. Gage,et al.  Prognostic utility of novel biomarkers of cardiovascular stress in patients with aortic stenosis undergoing valve replacement , 2015, Heart.

[28]  K. Pollard,et al.  Human Disease Modeling Reveals Integrated Transcriptional and Epigenetic Mechanisms of NOTCH1 Haploinsufficiency , 2015, Cell.

[29]  John D. Carroll,et al.  Clinical outcomes at 1 year following transcatheter aortic valve replacement. , 2015, JAMA.

[30]  H. Baumgartner,et al.  Usefulness of Global Left Ventricular Longitudinal Strain for Risk Stratification in Low Ejection Fraction, Low-Gradient Aortic Stenosis: Results From the Multicenter True or Pseudo-Severe Aortic Stenosis Study , 2015, Circulation. Cardiovascular imaging.

[31]  Philippe Pibarot,et al.  Assessment of paravalvular regurgitation following TAVR: a proposal of unifying grading scheme. , 2015, JACC. Cardiovascular imaging.

[32]  B. Iung,et al.  Influence of sex on mortality and perioperative outcomes in patients undergoing TAVR: insights from the FRANCE 2 registry. , 2015, Journal of the American College of Cardiology.

[33]  M. Mack,et al.  Paravalvular regurgitation after transcatheter aortic valve replacement with the Edwards sapien valve in the PARTNER trial: characterizing patients and impact on outcomes. , 2015, European heart journal.

[34]  E. Tuzcu,et al.  Outcomes of inoperable symptomatic aortic stenosis patients not undergoing aortic valve replacement: insight into the impact of balloon aortic valvuloplasty from the PARTNER trial (Placement of AoRtic TraNscathetER Valve trial). , 2015, JACC. Cardiovascular interventions.

[35]  J. Narula,et al.  Early aortic valve inflammation precedes calcification: a longitudinal FDG-PET/CT study. , 2015, Atherosclerosis.

[36]  H. Gray,et al.  Transcatheter aortic valve implantation in the United Kingdom: temporal trends, predictors of outcome, and 6-year follow-up: a report from the UK Transcatheter Aortic Valve Implantation (TAVI) Registry, 2007 to 2012. , 2015, Circulation.

[37]  Biykem Bozkurt,et al.  2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.

[38]  P. Pibarot,et al.  Valve tissue characterization by magnetic resonance imaging in calcific aortic valve disease. , 2014, The Canadian journal of cardiology.

[39]  G. Gerosa,et al.  Extracellular pyrophosphate is reduced in aortic interstitial valve cells acquiring a calcifying profile: implications for aortic valve calcification. , 2014, Atherosclerosis.

[40]  Vilmundur Gudnason,et al.  Association of low-density lipoprotein cholesterol-related genetic variants with aortic valve calcium and incident aortic stenosis. , 2014, JAMA.

[41]  M. Desai,et al.  Incremental Prognostic Value of Left Ventricular Global Longitudinal Strain in Patients With Aortic Stenosis and Preserved Ejection Fraction , 2014, Circulation. Cardiovascular imaging.

[42]  V. Gudnason,et al.  The prevalence of aortic stenosis in the elderly in Iceland and predictions for the coming decades: the AGES-Reykjavík study. , 2014, International journal of cardiology.

[43]  D. Adams,et al.  Survival and long-term outcomes following bioprosthetic vs mechanical aortic valve replacement in patients aged 50 to 69 years. , 2014, JAMA.

[44]  P. Wenaweser,et al.  Coronary artery disease severity and aortic stenosis: clinical outcomes according to SYNTAX score in patients undergoing transcatheter aortic valve implantation. , 2014, European heart journal.

[45]  L. Svensson,et al.  Impact of Aortic Annulus Size on Valve Hemodynamics and Clinical Outcomes After Transcatheter and Surgical Aortic Valve Replacement: Insights From the PARTNER Trial , 2014, Circulation. Cardiovascular interventions.

[46]  M. Enriquez-Sarano,et al.  Impact of aortic valve calcification, as measured by MDCT, on survival in patients with aortic stenosis: results of an international registry study. , 2014, Journal of the American College of Cardiology.

[47]  Marie-Chloé Boulanger,et al.  Basic mechanisms of calcific aortic valve disease. , 2014, The Canadian journal of cardiology.

[48]  W. O’Neill,et al.  Transcaval retrograde transcatheter aortic valve replacement for patients with no other access: first-in-man experience with CoreValve. , 2014, JACC. Cardiovascular interventions.

[49]  Chen Li,et al.  Circulating Level of miR-378 Predicts Left Ventricular Hypertrophy in Patients with Aortic Stenosis , 2014, PloS one.

[50]  Catherine M. Otto,et al.  Aortic-valve stenosis--from patients at risk to severe valve obstruction. , 2014, The New England journal of medicine.

[51]  K. Harjai,et al.  Aortic stenosis and coronary artery disease: what do we know? What don't we know? A comprehensive review of the literature with proposed treatment algorithms. , 2014, European heart journal.

[52]  R. Guyton,et al.  Comparison of transfemoral transcatheter aortic valve replacement performed in the catheterization laboratory (minimalist approach) versus hybrid operating room (standard approach): outcomes and cost analysis. , 2014, JACC. Cardiovascular interventions.

[53]  M. Mack,et al.  Comprehensive analysis of mortality among patients undergoing TAVR: results of the PARTNER trial. , 2014, Journal of the American College of Cardiology.

[54]  M. Pasic,et al.  Transcatheter aortic valve implantation in failed bioprosthetic surgical valves. , 2014, JAMA.

[55]  M. Weyant,et al.  Aortic valve calcification is mediated by a differential response of aortic valve interstitial cells to inflammation. , 2014, The Journal of surgical research.

[56]  K. Alexander,et al.  Futility, benefit, and transcatheter aortic valve replacement. , 2014, JACC. Cardiovascular interventions.

[57]  Michael J.A. Williams,et al.  The prevalence, incidence, progression, and risks of aortic valve sclerosis: a systematic review and meta-analysis. , 2014, Journal of the American College of Cardiology.

[58]  Y. Bossé,et al.  P2Y2 receptor represses IL-6 expression by valve interstitial cells through Akt: implication for calcific aortic valve disease. , 2014, Journal of molecular and cellular cardiology.

[59]  Nancy M Albert,et al.  2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, The Journal of thoracic and cardiovascular surgery.

[60]  Y. Bossé,et al.  Bicuspid aortic valve: identifying knowledge gaps and rising to the challenge from the International Bicuspid Aortic Valve Consortium (BAVCon). , 2014, Circulation.

[61]  Thoralf M Sundt,et al.  2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.

[62]  J. Coselli,et al.  Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. , 2014, Journal of the American College of Cardiology.

[63]  A. Jaffe,et al.  B-type natriuretic peptide clinical activation in aortic stenosis: impact on long-term survival. , 2014, Journal of the American College of Cardiology.

[64]  M. Dweck,et al.  High-sensitivity troponin I concentrations are a marker of an advanced hypertrophic response and adverse outcomes in patients with aortic stenosis , 2014, European heart journal.

[65]  Maurice Buchbinder,et al.  Transcatheter aortic-valve replacement with a self-expanding prosthesis. , 2014, The New England journal of medicine.

[66]  Lei Xu,et al.  GATA5 loss-of-function mutations associated with congenital bicuspid aortic valve. , 2014, International journal of molecular medicine.

[67]  J. Mehilli,et al.  Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial. , 2014, JAMA.

[68]  U. Wisløff,et al.  Prognostic Value of Circulating MicroRNA-210 Levels in Patients with Moderate to Severe Aortic Stenosis , 2014, PloS one.

[69]  P. Teirstein,et al.  Stratification of outcomes after transcatheter aortic valve replacement according to surgical inoperability for technical versus clinical reasons. , 2014, Journal of the American College of Cardiology.

[70]  E. Tuzcu,et al.  Transcatheter versus surgical aortic valve replacement in patients with diabetes and severe aortic stenosis at high risk for surgery: an analysis of the PARTNER Trial (Placement of Aortic Transcatheter Valve). , 2014, Journal of the American College of Cardiology.

[71]  Mi Zhang,et al.  MicroRNA-30b is a multifunctional regulator of aortic valve interstitial cells. , 2014, The Journal of thoracic and cardiovascular surgery.

[72]  P. Leprince,et al.  Postprocedural Aortic Regurgitation in Balloon-Expandable and Self-Expandable Transcatheter Aortic Valve Replacement Procedures: Analysis of Predictors and Impact on Long-Term Mortality Insights From the FRANCE2 Registry , 2014, Circulation.

[73]  J. Witztum,et al.  New therapeutic targets for calcific aortic valve stenosis: the lipoprotein(a)-lipoprotein-associated phospholipase A2-oxidized phospholipid axis. , 2014, Journal of the American College of Cardiology.

[74]  Y. Bossé,et al.  Elevated expression of lipoprotein-associated phospholipase A2 in calcific aortic valve disease: implications for valve mineralization. , 2014, Journal of the American College of Cardiology.

[75]  E. V. van Beek,et al.  18F-Sodium Fluoride Uptake Is a Marker of Active Calcification and Disease Progression in Patients With Aortic Stenosis , 2014, Circulation. Cardiovascular imaging.

[76]  J. Després,et al.  Lp‐PLA2 is associated with structural valve degeneration of bioprostheses , 2014, European journal of clinical investigation.

[77]  P. Pibarot,et al.  Mechanical strain induces the production of spheroid mineralized microparticles in the aortic valve through a RhoA/ROCK-dependent mechanism. , 2014, Journal of molecular and cellular cardiology.

[78]  E. Tuzcu,et al.  Outcomes of patients with chronic lung disease and severe aortic stenosis treated with transcatheter versus surgical aortic valve replacement or standard therapy: insights from the PARTNER trial (placement of AoRTic TraNscathetER Valve). , 2014, Journal of the American College of Cardiology.

[79]  P. Pibarot,et al.  The complex nature of discordant severe calcified aortic valve disease grading: new insights from combined Doppler echocardiographic and computed tomographic study. , 2013, Journal of the American College of Cardiology.

[80]  P. Pibarot,et al.  Impact of hypertension and renin–angiotensin system inhibitors in aortic stenosis , 2013, European journal of clinical investigation.

[81]  A. Zallone,et al.  Aortic valvular interstitial cells apoptosis and calcification are mediated by TNF-related apoptosis-inducing ligand. , 2013, International journal of cardiology.

[82]  R. Lange,et al.  The German Aortic Valve Registry (GARY): in-hospital outcome , 2013, European heart journal.

[83]  A. Bogers,et al.  Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. , 2013, Journal of the American College of Cardiology.

[84]  B. Nordestgaard,et al.  Elevated lipoprotein(a) and risk of aortic valve stenosis in the general population. , 2013, Journal of the American College of Cardiology.

[85]  M. Sandhu,et al.  Lipoprotein(a) levels, genotype and incident aortic stenosis: a prospective Mendelian randomization study and replication in a case-control cohort , 2013 .

[86]  H. Marques,et al.  Coronary artery calcium score to guide statin therapy in patients with elevated C-reactive protein and low LDL cholesterol levels: a cost-effectiveness analysis , 2013 .

[87]  R. Bonow,et al.  Current management of calcific aortic stenosis. , 2013, Circulation research.

[88]  E. Tuzcu,et al.  Severe aortic stenosis and coronary artery disease--implications for management in the transcatheter aortic valve replacement era: a comprehensive review. , 2013, Journal of the American College of Cardiology.

[89]  F. Tubach,et al.  Progression of aortic valve stenosis is associated with bone remodelling and secondary hyperparathyroidism in elderly patients--the COFRASA study. , 2013, European heart journal.

[90]  P. Kovanen,et al.  Modified Lipoprotein-Derived Lipid Particles Accumulate in Human Stenotic Aortic Valves , 2013, PloS one.

[91]  R. Brooks,et al.  Osteoprotegerin Inhibits Aortic Valve Calcification and Preserves Valve Function in Hypercholesterolemic Mice , 2013, PloS one.

[92]  J. Després,et al.  Lipoprotein lipase in aortic valve stenosis is associated with lipid retention and remodelling , 2013, European journal of clinical investigation.

[93]  M. Yacoub,et al.  Nano-analytical electron microscopy reveals fundamental insights into human cardiovascular tissue calcification. , 2013, Nature materials.

[94]  Y. Bossé,et al.  Inflammation Is Associated with the Remodeling of Calcific Aortic Valve Disease , 2013, Inflammation.

[95]  J. Bavaria,et al.  Predictors of Mortality and Outcomes of Therapy in Low-Flow Severe Aortic Stenosis: A Placement of Aortic Transcatheter Valves (PARTNER) Trial Analysis , 2013, Circulation.

[96]  Elena Aikawa,et al.  Macrophage-Derived Matrix Vesicles: An Alternative Novel Mechanism for Microcalcification in Atherosclerotic Plaques , 2013, Circulation research.

[97]  Antonio Colombo,et al.  Clinical ResearchInterventional CardiologyIncidence, Predictors, and Outcomes of Aortic Regurgitation After Transcatheter Aortic Valve Replacement: Meta-Analysis and Systematic Review of Literature , 2013 .

[98]  M. Andreassi,et al.  Sequencing of NOTCH1, GATA5, TGFBR1 and TGFBR2 genes in familial cases of bicuspid aortic valve , 2013, BMC Medical Genetics.

[99]  E. Aikawa,et al.  Visualizing novel concepts of cardiovascular calcification. , 2013, Trends in cardiovascular medicine.

[100]  Susheel Kodali,et al.  Paravalvular leak after transcatheter aortic valve replacement: the new Achilles' heel? A comprehensive review of the literature. , 2013, Journal of the American College of Cardiology.

[101]  M. Mack,et al.  The heart team of cardiovascular care. , 2013, Journal of the American College of Cardiology.

[102]  K. J. Grande-Allen,et al.  Smad2-dependent glycosaminoglycan elongation in aortic valve interstitial cells enhances binding of LDL to proteoglycans. , 2013, Cardiovascular pathology.

[103]  G. Heinze,et al.  Two-Dimensional Strain for the Assessment of Left Ventricular Function in Low Flow–Low Gradient Aortic Stenosis, Relationship to Hemodynamics, and Outcome: A Substudy of the Multicenter TOPAS Study , 2013, Circulation. Cardiovascular imaging.

[104]  P. Jüni,et al.  Predictors of functional decline in elderly patients undergoing transcatheter aortic valve implantation (TAVI). , 2013, European heart journal.

[105]  Y. Bossé,et al.  NOTCH1 genetic variants in patients with tricuspid calcific aortic valve stenosis. , 2013, The Journal of heart valve disease.

[106]  Kathleen F. Kerr,et al.  Genetic associations with valvular calcification and aortic stenosis. , 2013, The New England journal of medicine.

[107]  M. Mack,et al.  Venn diagrams in cardiovascular disease: the Heart Team concept. , 2013, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[108]  P. Pibarot,et al.  Stress echocardiography to assess stenosis severity and predict outcome in patients with paradoxical low-flow, low-gradient aortic stenosis and preserved LVEF. , 2013, JACC. Cardiovascular imaging.

[109]  Andrew S Flett,et al.  Human non-contrast T1 values and correlation with histology in diffuse fibrosis , 2013, Heart.

[110]  M. Dweck,et al.  Calcific aortic stenosis: a disease of the valve and the myocardium. , 2012, Journal of the American College of Cardiology.

[111]  P. Pibarot,et al.  Low-flow, low-gradient aortic stenosis with normal and depressed left ventricular ejection fraction. , 2012, Journal of the American College of Cardiology.

[112]  J. Cleveland,et al.  Biglycan Induces the Expression of Osteogenic Factors in Human Aortic Valve Interstitial Cells via Toll-Like Receptor-2 , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[113]  B. Iung,et al.  Degenerative calcific aortic stenosis: a natural history , 2012, Heart.

[114]  F. Maltais,et al.  Chronic obstructive pulmonary disease in patients undergoing transcatheter aortic valve implantation: insights on clinical outcomes, prognostic markers, and functional status changes. , 2012, JACC. Cardiovascular interventions.

[115]  G. Faggian,et al.  Prognostic value of myocardial fibrosis in patients with severe aortic valve stenosis. , 2012, The Journal of thoracic and cardiovascular surgery.

[116]  O. Alfieri,et al.  Guidelines on the management of valvular heart disease (version 2012). , 2012, European heart journal.

[117]  O. Alfieri,et al.  Guidelines on the management of valvular heart disease. , 2007, European heart journal.

[118]  H. Schirmer,et al.  The evolving epidemiology of valvular aortic stenosis. The Tromsø Study , 2012, Heart.

[119]  A. Kirtane,et al.  The impact of frailty status on survival after transcatheter aortic valve replacement in older adults with severe aortic stenosis: a single-center experience. , 2012, JACC. Cardiovascular interventions.

[120]  E. Donal,et al.  Determinants and Prognostic Significance of Exercise Pulmonary Hypertension in Asymptomatic Severe Aortic Stenosis , 2012, Circulation.

[121]  Martin B Leon,et al.  Health-related quality of life after transcatheter or surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results from the PARTNER (Placement of AoRTic TraNscathetER Valve) Trial (Cohort A). , 2012, Journal of the American College of Cardiology.

[122]  J. Després,et al.  Impact of metabolic syndrome on progression of aortic stenosis: influence of age and statin therapy. , 2012, Journal of the American College of Cardiology.

[123]  E. Staal,et al.  Hypertension in Aortic Stenosis: Implications for Left Ventricular Structure and Cardiovascular Events , 2012, Hypertension.

[124]  Su‐Li Cheng,et al.  TNFR1-activated reactive oxidative species signals up-regulate osteogenic Msx2 programs in aortic myofibroblasts. , 2012, Endocrinology.

[125]  D. Wood,et al.  Clinical ResearchInterventional CardiologyTranscatheter Aortic Valve Replacement: Outcomes of Patients With Moderate or Severe Mitral Regurgitation , 2012 .

[126]  R. Kronmal,et al.  Aortic valve calcium independently predicts coronary and cardiovascular events in a primary prevention population. , 2012, JACC. Cardiovascular imaging.

[127]  P. Leprince,et al.  Registry of transcatheter aortic-valve implantation in high-risk patients. , 2012, The New England journal of medicine.

[128]  Scott Lim,et al.  Two-year outcomes after transcatheter or surgical aortic-valve replacement. , 2012, The New England journal of medicine.

[129]  Susheel Kodali,et al.  Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. , 2012, The New England journal of medicine.

[130]  P. Jüni,et al.  Evaluation of multidimensional geriatric assessment as a predictor of mortality and cardiovascular events after transcatheter aortic valve implantation. , 2012, JACC. Cardiovascular interventions.

[131]  Y. Bossé,et al.  ATP acts as a survival signal and prevents the mineralization of aortic valve. , 2012, Journal of molecular and cellular cardiology.

[132]  B. Carabello,et al.  Contemporary Reviews in Cardiovascular Medicine Hemodynamics in the Cardiac Catheterization Laboratory of the 21st Century , 2012 .

[133]  J. Lessick,et al.  Frequency, Determinants and Outcome of Pulmonary Hypertension in Patients With Aortic Valve Stenosis , 2012, American Journal of the Medical Sciences.

[134]  B. Iung,et al.  Detection of 18fluoride sodium accumulation by positron emission tomography in calcified stenotic aortic valves. , 2012, American Journal of Cardiology.

[135]  M. Boffa,et al.  Lipoprotein(a): more interesting than ever after 50 years , 2012, Current opinion in lipidology.

[136]  Sanjay Kaul,et al.  2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement. , 2012, Journal of the American College of Cardiology.

[137]  E. V. van Beek,et al.  Assessment of Valvular Calcification and Inflammation by Positron Emission Tomography in Patients With Aortic Stenosis , 2012, Circulation.

[138]  A. D. Cunningham,et al.  Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry. , 2011, Journal of the American College of Cardiology.

[139]  J. Després,et al.  Angiotensin receptor blockers are associated with a lower remodelling score of stenotic aortic valves , 2011, European journal of clinical investigation.

[140]  L. Svensson,et al.  Health-Related Quality of Life After Transcatheter Aortic Valve Replacement in Inoperable Patients With Severe Aortic Stenosis , 2011, Circulation.

[141]  David A. Bluemke,et al.  Cardiac remodeling at the population level—risk factors, screening, and outcomes , 2011, Nature Reviews Cardiology.

[142]  K. J. Grande-Allen,et al.  Calcific Aortic Valve Disease : Not Simply a Degenerative Process A Review and Agenda for Research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group , 2012 .

[143]  W. Edwards,et al.  Incidence of aortic complications in patients with bicuspid aortic valves. , 2011, JAMA.

[144]  S. Nazarian.  Clinical ResearchHeart Rhythm Disorder: Editorial CommentIs Ventricular Arrhythmia a Possible Mediator of the Association Between Aortic Stenosis-Related Midwall Fibrosis and Mortality?⁎ , 2011 .

[145]  S. Kapadia,et al.  Assessment of left ventricular function in aortic stenosis , 2011, Nature Reviews Cardiology.

[146]  Robert M Nerem,et al.  Discovery of shear- and side-specific mRNAs and miRNAs in human aortic valvular endothelial cells. , 2011, American journal of physiology. Heart and circulatory physiology.

[147]  T. Sundt,et al.  Aortic Valve Replacement in the Elderly: Determinants of Late Outcome , 2011, Circulation.

[148]  M. Beer,et al.  Low-gradient aortic valve stenosis myocardial fibrosis and its influence on function and outcome. , 2011, Journal of the American College of Cardiology.

[149]  R. Winchester,et al.  Circulating Activated and Effector Memory T Cells Are Associated with Calcification and Clonal Expansions in Bicuspid and Tricuspid Valves of Calcific Aortic Stenosis , 2011, The Journal of Immunology.

[150]  Javier Bermejo,et al.  Diet-Induced Aortic Valve Disease in Mice Haploinsufficient for the Notch Pathway Effector RBPJK/CSL , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[151]  Michael D Hope,et al.  4D flow CMR in assessment of valve-related ascending aortic disease. , 2011, JACC. Cardiovascular imaging.

[152]  T. Edvardsen,et al.  Prognostic usefulness of circulating high-sensitivity troponin T in aortic stenosis and relation to echocardiographic indexes of cardiac function and anatomy. , 2011, The American journal of cardiology.

[153]  G. Andelfinger,et al.  Loss of Gata5 in mice leads to bicuspid aortic valve. , 2011, The Journal of clinical investigation.

[154]  Craig A Simmons,et al.  Cell–Matrix Interactions in the Pathobiology of Calcific Aortic Valve Disease: Critical Roles for Matricellular, Matricrine, and Matrix Mechanics Cues , 2011, Circulation research.

[155]  Stuart J Pocock,et al.  Transcatheter versus surgical aortic-valve replacement in high-risk patients. , 2011, The New England journal of medicine.

[156]  Julio E. Pérez,et al.  The Adverse Impact of Diabetes Mellitus on Left Ventricular Remodeling and Function in Patients With Severe Aortic Stenosis , 2011, Circulation. Heart failure.

[157]  A. Franco‐Cereceda,et al.  Upregulation of the 5-Lipoxygenase Pathway in Human Aortic Valves Correlates With Severity of Stenosis and Leads to Leukotriene-Induced Effects on Valvular Myofibroblasts , 2011, Circulation.

[158]  Sean M. O'Brien,et al.  Fifteen-year outcome trends for valve surgery in North America. , 2011, The Annals of thoracic surgery.

[159]  Pierre Croisille,et al.  Assessment of myocardial fibrosis with cardiovascular magnetic resonance. , 2011, Journal of the American College of Cardiology.

[160]  J. Després,et al.  Oxidized low-density lipoprotein, angiotensin II and increased waist cirumference are associated with valve inflammation in prehypertensive patients with aortic stenosis. , 2010, International journal of cardiology.

[161]  E. Podrez,et al.  Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands , 2010, Nature.

[162]  S. Pocock,et al.  Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. , 2010, The New England journal of medicine.

[163]  T. Sundt,et al.  Spectrum and Outcome of Reoperations After the Ross Procedure , 2010, Circulation.

[164]  T. David.  Reoperations after the Ross procedure. , 2010, Circulation.

[165]  R. Siegel,et al.  Prognostic value of E/E' ratio in patients with unoperated severe aortic stenosis. , 2010, JACC. Cardiovascular imaging.

[166]  F. Neumann,et al.  Inconsistent grading of aortic valve stenosis by current guidelines: haemodynamic studies in patients with apparently normal left ventricular function , 2010, Heart.

[167]  L. Tarantini,et al.  Prognostic effect of inappropriately high left ventricular mass in asymptomatic severe aortic stenosis , 2010, Heart.

[168]  C. Rochitte,et al.  Prognostic significance of myocardial fibrosis quantification by histopathology and magnetic resonance imaging in patients with severe aortic valve disease. , 2010, Journal of the American College of Cardiology.

[169]  J. Després,et al.  Age-related differences in the pathogenesis of calcific aortic stenosis: the potential role of resistin. , 2010, International journal of cardiology.

[170]  Y. Bossé,et al.  Increased biglycan in aortic valve stenosis leads to the overexpression of phospholipid transfer protein via Toll-like receptor 2. , 2010, The American journal of pathology.

[171]  J. Daubert,et al.  Risk stratification in asymptomatic moderate to severe aortic stenosis: the importance of the valvular, arterial and ventricular interplay , 2010, Heart.

[172]  C. Gohlke-Bärwolf,et al.  Effect of obesity on left ventricular mass and systolic function in patients with asymptomatic aortic stenosis (a Simvastatin Ezetimibe in Aortic Stenosis [SEAS] substudy). , 2010, American Journal of Cardiology.

[173]  J. Després,et al.  Metabolic syndrome is associated with more pronounced impairment of left ventricle geometry and function in patients with calcific aortic stenosis: a substudy of the ASTRONOMER (Aortic Stenosis Progression Observation Measuring Effects of Rosuvastatin). , 2010, Journal of the American College of Cardiology.

[174]  P. Pibarot,et al.  Usefulness of exercise-stress echocardiography for risk stratification of true asymptomatic patients with aortic valve stenosis , 2010, European heart journal.

[175]  F. Ohsuzu,et al.  Deficiency of Interleukin-1 Receptor Antagonist Induces Aortic Valve Disease in BALB/c Mice , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[176]  H. Baumgartner,et al.  Validation of conventional and simplified methods to calculate projected valve area at normal flow rate in patients with low flow, low gradient aortic stenosis: the multicenter TOPAS (True or Pseudo Severe Aortic Stenosis) study. , 2010, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[177]  M. Alley,et al.  Bicuspid Aortic Valve : Four-dimensional MR Evaluation of Ascending Aortic Systolic Flow Patterns 1 , 2010 .

[178]  E. Donal,et al.  Impact of global left ventricular afterload on left ventricular function in asymptomatic severe aortic stenosis: a two-dimensional speckle-tracking study. , 2010, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[179]  K. Sliwa,et al.  Incidence and characteristics of newly diagnosed rheumatic heart disease in urban African adults: insights from the heart of Soweto study. , 2010, European heart journal.

[180]  E. Donal,et al.  Prognostic effect of long-axis left ventricular dysfunction and B-type natriuretic peptide levels in asymptomatic aortic stenosis. , 2010, The American journal of cardiology.

[181]  K. Teo,et al.  Effect of Lipid Lowering With Rosuvastatin on Progression of Aortic Stenosis: Results of the Aortic Stenosis Progression Observation: Measuring Effects of Rosuvastatin (ASTRONOMER) Trial , 2010, Circulation.

[182]  A. C. Durán,et al.  Bicuspid aortic valves with different spatial orientations of the leaflets are distinct etiological entities. , 2009, Journal of the American College of Cardiology.

[183]  D. Srivastava,et al.  Notch1 represses osteogenic pathways in aortic valve cells. , 2009, Journal of molecular and cellular cardiology.

[184]  Claire Duvernoy,et al.  Evaluation of Patients With Severe Symptomatic Aortic Stenosis Who Do Not Undergo Aortic Valve Replacement: The Potential Role of Subjectively Overestimated Operative Risk , 2009, Circulation. Cardiovascular quality and outcomes.

[185]  Y. Bossé,et al.  Refining Molecular Pathways Leading to Calcific Aortic Valve Stenosis by Studying Gene Expression Profile of Normal and Calcified Stenotic Human Aortic Valves , 2009, Circulation. Cardiovascular genetics.

[186]  M. Ruel,et al.  Prosthesis-patient mismatch is less frequent and more clinically indolent in patients operated for aortic insufficiency. , 2009, The Journal of thoracic and cardiovascular surgery.

[187]  M. Beer,et al.  Impact of Myocardial Fibrosis in Patients With Symptomatic Severe Aortic Stenosis , 2009, Circulation.

[188]  I. Kronzon,et al.  Osteoporosis treatment and progression of aortic stenosis. , 2009, The American journal of cardiology.

[189]  J. Geddes,et al.  What is a randomised controlled trial? , 2009, Epidemiologia e Psichiatria Sociale.

[190]  C. Tribouilloy,et al.  Outcome after aortic valve replacement for low-flow/low-gradient aortic stenosis without contractile reserve on dobutamine stress echocardiography. , 2009, Journal of the American College of Cardiology.

[191]  A. Tselepis,et al.  The role of lipoprotein-associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma. , 2009, Biochimica et biophysica acta.

[192]  P. Libby,et al.  Arterial and Aortic Valve Calcification Abolished by Elastolytic Cathepsin S Deficiency in Chronic Renal Disease , 2009, Circulation.

[193]  G. Cioffi,et al.  Low-flow aortic stenosis in asymptomatic patients: valvular-arterial impedance and systolic function from the SEAS Substudy. , 2009, JACC. Cardiovascular imaging.

[194]  T. Sundt,et al.  Ministernotomy versus conventional sternotomy for aortic valve replacement: a systematic review and meta-analysis. , 2009, The Journal of thoracic and cardiovascular surgery.

[195]  P. Price,et al.  Tissue-nonspecific Alkaline Phosphatase Is Required for the Calcification of Collagen in Serum , 2009, Journal of Biological Chemistry.

[196]  Frederick J. Schoen,et al.  Evolving Concepts of Cardiac Valve Dynamics: The Continuum of Development, Functional Structure, Pathobiology, and Tissue Engineering , 2008, Circulation.

[197]  J. Chambers,et al.  Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. , 2008, The New England journal of medicine.

[198]  R. Brooks,et al.  Dysregulation of antioxidant mechanisms contributes to increased oxidative stress in calcific aortic valvular stenosis in humans. , 2008, Journal of the American College of Cardiology.

[199]  J. Witztum,et al.  The role of oxidized phospholipids in mediating lipoprotein(a) atherogenicity , 2008, Current opinion in lipidology.

[200]  Jeevanantham Rajeswaran,et al.  Survival after valve replacement for aortic stenosis: implications for decision making. , 2008, The Journal of thoracic and cardiovascular surgery.

[201]  Mario J. Garcia,et al.  Influence of concentric left ventricular remodeling on early mortality after aortic valve replacement. , 2008, The Annals of thoracic surgery.

[202]  C. Tribouilloy,et al.  Aortic valve replacement for low-flow/low-gradient aortic stenosis operative risk stratification and long-term outcome: a European multicenter study. , 2008, Journal of the American College of Cardiology.

[203]  Y. Bossé,et al.  Genomics: the next step to elucidate the etiology of calcific aortic valve stenosis. , 2008, Journal of the American College of Cardiology.

[204]  E. Bassi,et al.  Oxidant Generation Predominates Around Calcifying Foci and Enhances Progression of Aortic Valve Calcification , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[205]  J. Després,et al.  Association Between Plasma LDL Particle Size, Valvular Accumulation of Oxidized LDL, and Inflammation in Patients With Aortic Stenosis , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[206]  J. Després,et al.  Association between circulating oxidised low-density lipoprotein and fibrocalcific remodelling of the aortic valve in aortic stenosis , 2007, Heart.

[207]  P. Pibarot,et al.  Paradoxical Low-Flow, Low-Gradient Severe Aortic Stenosis Despite Preserved Ejection Fraction Is Associated With Higher Afterload and Reduced Survival , 2007, Circulation.

[208]  I. Šteiner,et al.  Bone formation in cardiac valves: a histopathological study of 128 cases , 2007, Virchows Archiv.

[209]  R. Bonow,et al.  Calcific aortic stenosis: an update , 2007, Nature Clinical Practice Cardiovascular Medicine.

[210]  J. Mirelis,et al.  Guidelines on the management of valvular heart disease. , 2007, European heart journal.

[211]  S. Takai,et al.  Angiotensin receptor-1 blocker inhibits atherosclerotic changes and endothelial disruption of the aortic valve in hypercholesterolemic rabbits. , 2007, Journal of the American College of Cardiology.

[212]  Shinsuke Yuasa,et al.  Chondromodulin-I maintains cardiac valvular function by preventing angiogenesis , 2006, Nature Medicine.

[213]  J. Gardin,et al.  Burden of valvular heart diseases: a population-based study , 2006, The Lancet.

[214]  M. Mäyränpää,et al.  Increased Expression of Elastolytic Cathepsins S, K, and V and Their Inhibitor Cystatin C in Stenotic Aortic Valves , 2006 .

[215]  R. Hinton,et al.  Extracellular Matrix Remodeling and Organization in Developing and Diseased Aortic Valves , 2006, Circulation research.

[216]  Helmut Baumgartner,et al.  Guidelines on the management of valvular heart disease The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology , 2007 .

[217]  M. Mäyränpää,et al.  Possible role for mast cell-derived cathepsin G in the adverse remodelling of stenotic aortic valves. , 2006, European heart journal.

[218]  P. Pibarot,et al.  Distribution of SPARC during neovascularisation of degenerative aortic stenosis , 2006, Heart.

[219]  R. Kronmal,et al.  Features of the Metabolic Syndrome and Diabetes Mellitus as Predictors of Aortic Valve Calcification in the Multi-Ethnic Study of Atherosclerosis , 2006, Circulation.

[220]  R. Bonow,et al.  Human degenerative valve disease is associated with up-regulation of low-density lipoprotein receptor-related protein 5 receptor-mediated bone formation. , 2006, Journal of the American College of Cardiology.

[221]  E. Canalis,et al.  Notch 1 Overexpression Inhibits Osteoblastogenesis by Suppressing Wnt/β-Catenin but Not Bone Morphogenetic Protein Signaling* , 2006, Journal of Biological Chemistry.

[222]  V. Probst,et al.  Familial Aggregation of Calcific Aortic Valve Stenosis in the Western Part of France , 2006, Circulation.

[223]  H. Baumgartner,et al.  Projected Valve Area at Normal Flow Rate Improves the Assessment of Stenosis Severity in Patients With Low-Flow, Low-Gradient Aortic Stenosis: The Multicenter TOPAS (Truly or Pseudo-Severe Aortic Stenosis) Study , 2006, Circulation.

[224]  Philippe Ravaud,et al.  Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? , 2005, European heart journal.

[225]  D. Srivastava,et al.  Mutations in NOTCH1 cause aortic valve disease , 2005, Nature.

[226]  J. Lommi,et al.  Left ventricular hypertrophy in aortic valve stenosis: preventive or promotive of systolic dysfunction and heart failure? , 2005, European heart journal.

[227]  M. Simon,et al.  Prognostic Importance of Quantitative Exercise Doppler Echocardiography in Asymptomatic Valvular Aortic Stenosis , 2005, Circulation.

[228]  Damien Garcia,et al.  Reduced systemic arterial compliance impacts significantly on left ventricular afterload and function in aortic stenosis: implications for diagnosis and treatment. , 2005, Journal of the American College of Cardiology.

[229]  Patrick Royston,et al.  Generic, Simple Risk Stratification Model for Heart Valve Surgery , 2005, Circulation.

[230]  Rosario V. Freeman,et al.  Spectrum of Calcific Aortic Valve Disease: Pathogenesis, Disease Progression, and Treatment Strategies , 2005, Circulation.

[231]  R. Prescott,et al.  A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. , 2005, The New England journal of medicine.

[232]  Su‐Li Cheng,et al.  Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals. , 2005, The Journal of clinical investigation.

[233]  F. Dagenais,et al.  Calcification of human valve interstitial cells is dependent on alkaline phosphatase activity. , 2005, The Journal of heart valve disease.

[234]  Craig A. Simmons,et al.  Spatial Heterogeneity of Endothelial Phenotypes Correlates With Side-Specific Vulnerability to Calcification in Normal Porcine Aortic Valves , 2005, Circulation research.

[235]  W. Roberts,et al.  Frequency by Decades of Unicuspid, Bicuspid, and Tricuspid Aortic Valves in Adults Having Isolated Aortic Valve Replacement for Aortic Stenosis, With or Without Associated Aortic Regurgitation , 2005, Circulation.

[236]  M. Mäyränpää,et al.  Induction of local angiotensin II-producing systems in stenotic aortic valves. , 2004, Journal of the American College of Cardiology.

[237]  J. Mehta,et al.  Regulatory role of endothelium in the expression of genes affecting arterial calcification. , 2004, Biochemical and biophysical research communications.

[238]  Lisa J. Martin,et al.  Bicuspid aortic valve is heritable. , 2004, Journal of the American College of Cardiology.

[239]  C. Tribouilloy,et al.  Low‐Gradient Aortic Stenosis Operative Risk Stratification and Predictors for Long‐Term Outcome: A Multicenter Study Using Dobutamine Stress Hemodynamics , 2003, Circulation.

[240]  Philippe Ravaud,et al.  A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. , 2003, European heart journal.

[241]  Dudley J Pennell,et al.  Functional Changes in Coronary Microcirculation After Valve Replacement in Patients With Aortic Stenosis , 2003, Circulation.

[242]  Rolf Fimmers,et al.  Silent and apparent cerebral embolism after retrograde catheterisation of the aortic valve in valvular stenosis: a prospective, randomised study , 2003, The Lancet.

[243]  I. Kronzon,et al.  The risk of the development of aortic stenosis in patients with "benign" aortic valve thickening. , 2002, Archives of internal medicine.

[244]  C. Otto,et al.  Association of Angiotensin-Converting Enzyme With Low-Density Lipoprotein in Aortic Valvular Lesions and in Human Plasma , 2002, Circulation.

[245]  L. Demer.  Vascular calcification and osteoporosis: inflammatory responses to oxidized lipids. , 2002, International journal of epidemiology.

[246]  D. Pennell,et al.  Mechanisms of Coronary Microcirculatory Dysfunction in Patients With Aortic Stenosis and Angiographically Normal Coronary Arteries , 2002, Circulation.

[247]  Y. Soini,et al.  Progression of human aortic valve stenosis is associated with tenascin-C expression. , 2002, Journal of the American College of Cardiology.

[248]  B. Gersh,et al.  Smoking and obesity are associated with the progression of aortic stenosis. , 2001, The American journal of geriatric cardiology.

[249]  B. Astor,et al.  Mortality after aortic valve replacement: results from a nationally representative database. , 2000, The Annals of thoracic surgery.

[250]  M. Schemper,et al.  Predictors of outcome in severe, asymptomatic aortic stenosis. , 2000, The New England journal of medicine.

[251]  B. Lorell,et al.  Left ventricular hypertrophy: pathogenesis, detection, and prognosis. , 2000, Circulation.

[252]  R. Choudhury,et al.  New insights into the progression of aortic stenosis: implications for secondary prevention. , 2000, Circulation.

[253]  R. Pai,et al.  New insights into the progression of aortic stenosis: implications for secondary prevention. , 2000, Circulation.

[254]  Bonnie K. Lind,et al.  Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. , 1999, The New England journal of medicine.

[255]  Marwan A. Simaan,et al.  Minimally Invasive Estimation of Systemic Vascular Parameters , 1999, Annals of Biomedical Engineering.

[256]  JanNilsson,et al.  Presence of Oxidized Low Density Lipoprotein in Nonrheumatic Stenotic Aortic Valves , 1999 .

[257]  C M Otto,et al.  Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome. , 1997, Circulation.

[258]  F. Parhami,et al.  Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[259]  Catherine M. Otto,et al.  Clinical Factors Associated With Calcific Aortic Valve Disease , 1997 .

[260]  F. Eberli,et al.  Angina pectoris in patients with aortic stenosis and normal coronary arteries. Mechanisms and pathophysiological concepts. , 1997, Circulation.

[261]  J. Heikkilä,et al.  Natural history of aortic valve stenosis of varying severity in the elderly. , 1996, The American journal of cardiology.

[262]  C. Otto,et al.  Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of 'degenerative' valvular aortic stenosis. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[263]  Hong-Bing Shu,et al.  TRADD–TRAF2 and TRADD–FADD Interactions Define Two Distinct TNF Receptor 1 Signal Transduction Pathways , 1996, Cell.

[264]  I. Palacios,et al.  Three‐Year Outcome After Balloon Aortic Valvuloplast: Insights Into Prognosis of Valvular Aortic Stenosis , 1994, Circulation.

[265]  S. Leeder,et al.  A population based study , 1993, The Medical journal of Australia.

[266]  J. Heikkilä,et al.  Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. , 1993, Journal of the American College of Cardiology.

[267]  R M Lang,et al.  Sex‐Associated Differences in Left Ventricular Function in Aortic Stenosis of the Elderly , 1992, Circulation.

[268]  W. P. Harvey,et al.  Development and progression of aortic valve stenosis: Atherosclerosis risk factors—a causal relationship? a clinical morphologic study , 1991, Clinical cardiology.

[269]  W. Aronow,et al.  Correlation of serum lipids, calcium, and phosphorus, diabetes mellitus and history of systemic hypertension with presence or absence of calcified or thickened aortic cusps or root in elderly patients. , 1987, The American journal of cardiology.

[270]  V. Fuster,et al.  Left ventricular function after myocardial infarction: clinical and angiographic correlations. , 1985, Journal of the American College of Cardiology.

[271]  Franz Schwarz,et al.  The Effect of Aortic Valve Replacement on Survival , 1982, Circulation.

[272]  J. Dumesnil,et al.  A Mathematical Model of the Dynamic Geometry of the Intact Left Ventricle Its Application to Clinical Data , 1979, Circulation.

[273]  H. Soroff,et al.  Partial and complete prostheses in aortic insufficiency. , 1960, The Journal of thoracic and cardiovascular surgery.

[274]  P. Leprince,et al.  Impact of coronary artery disease in patients undergoing transcatheter aortic valve replacement: Insights from the FRANCE-2 registry , 2018 .

[275]  J. Rodés‐Cabau,et al.  Management of Coronary Disease in the Era of Transcatheter Aortic Valve Replacement: Comprehensive Review of the Literature. , 2015, Interventional cardiology clinics.

[276]  Y. Bossé,et al.  Impact of plasma Lp-PLA2 activity on the progression of aortic stenosis: the PROGRESSA study. , 2015, JACC. Cardiovascular imaging.

[277]  M. Dweck,et al.  F-NaF Uptake Is a Marker of Active Calcification and Disease Progression in Patients with Aortic Stenosis , 2014 .

[278]  S. Takai,et al.  Angiotensin II promotes aortic valve thickening independent of elevated blood pressure in apolipoprotein-E deficient mice. , 2013, Atherosclerosis.

[279]  L. Sade,et al.  The Turkish registry of heart valve disease. , 2013, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.

[280]  Mark D. Huffman,et al.  Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association. , 2013, Circulation.

[281]  Mark D. Huffman,et al.  Heart disease and stroke statistics--2013 update: a report from the American Heart Association. , 2013, Circulation.

[282]  M. Cheitlin.  Midwall Fibrosis Is an Independent Predictor of Mortality in Patients With Aortic Stenosis , 2012 .

[283]  Josep Rodés-Cabau,et al.  Transcatheter aortic valve implantation: current and future approaches , 2012, Nature Reviews Cardiology.

[284]  R. Boone,et al.  Outcomes of Patients With Moderate or Severe Mitral Regurgitation , 2012 .

[285]  T. Huber,et al.  Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients , 2012 .

[286]  M. Maganti,et al.  When is the Ross operation a good option to treat aortic valve disease? , 2010, The Journal of thoracic and cardiovascular surgery.

[287]  大窄マリアナ今日美.  Estrogen inhibits vascular calcification via vascular RANKL system : common mechanism of osteoporosis and vascular calcification , 2010 .

[288]  H. Ryoo,et al.  Tumor necrosis factor-alpha increases alkaline phosphatase expression in vascular smooth muscle cells via MSX2 induction. , 2010, Biochemical and biophysical research communications.

[289]  J. Chambers,et al.  Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. , 2009, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[290]  Sean M. O'Brien,et al.  Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database. , 2009, The Journal of thoracic and cardiovascular surgery.

[291]  J. Chambers,et al.  Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. , 2009, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[292]  M. Mack,et al.  Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement. , 2008, The Journal of thoracic and cardiovascular surgery.

[293]  Teiji Wada,et al.  RANKL-RANK signaling in osteoclastogenesis and bone disease. , 2006, Trends in molecular medicine.

[294]  S. Hagl,et al.  Receptor activator of nuclear factor κB ligand and osteoprotegerin regulate aortic valve calcification , 2004 .

[295]  M. Yacoub,et al.  Phenotypic and functional characterization of interstitial cells from human heart valves, pericardium and skin. , 2000, The Journal of heart valve disease.

[296]  R. Brooks,et al.  Implications for Decision-Making , 1995 .

[297]  K. Johnson.  An Update. , 1984, Journal of food protection.